Recently, it is found that Nrf2 activation alone is sufficient to attenuate the progression of NASH-related fibrosis as demonstrated in Huh 7.5 cells and livers of NASH rat model26. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatohepatitis.